NSRI
ONC

New Silk Road Investment’s BeOne Medicines Ltd ONC Stock Holding History

New Silk Road Investment’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,400
Closed -$641K – 17
2022
Q1 		$641K Buy
+3,400
New +$723K 0.6% 15
2020
Q3 		– Sell
-11,250
Closed -$2.12M – 14
2020
Q2 		$2.12M Sell
11,250
-12,450
-53% -$2.03M 1.57% 9
2020
Q1 		$2.92M Buy
+23,700
New +$3.71M 3.39% 8
2019
Q4 		– Sell
-17,258
Closed -$2.11M – 17
2019
Q3 		$2.11M Sell
17,258
-106,117
-86% -$14.1M 0.8% 12
2019
Q2 		$15.3M Buy
+123,375
New +$15.7M 5.52% 6

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

New Silk Road Investment's ONC Position: Q2 2022 in Review

New Silk Road Investment sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 3,400 shares — an estimated $641K sold.

New Silk Road Investment first reported a position in ONC in Q2 2019 and held it in 5 quarters. The position peaked at $15.3M in Q2 2019. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • New Silk Road Investment reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • New Silk Road Investment sold 3,400 BeOne Medicines Ltd shares in Q2 2022, an estimated $641K.
  • New Silk Road Investment first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 5 quarters.
  • New Silk Road Investment's BeOne Medicines Ltd position peaked at $15.3M in Q2 2019.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on New Silk Road Investment's 13F filing for Q2 2022, filed 10 Aug 2022.